50.67
  Price1.50%   +0.75
(After Hours: 50.61 -0.0600 -0.12%)
May-16-22 06:46AM Why Dynavax Stock Won on a Losing Monday for the MarketThe Motley Fool
02:53AM Top Analyst Reports for NVIDIA, Home Depot, Pfizer & OthersZacks Investment Research
May-14-22 03:45AM 12 stocks to consider for the next leg of the bull marketMarketWatch
10:30AM 3 Supercharged Dividend Stocks to Buy in the Stock Market Sell-OffThe Motley Fool
May-14-22 08:29AM 12 stocks to consider for the next leg of the bull marketMarketWatch
07:04AM 3 Dirt-Cheap Stocks You Can Buy Right NowThe Motley Fool
May-13-22 11:00AM 3 Reasons That Novavax Investors Could Be Looking For The DoorThe Motley Fool
10:41AM Some patients and physicians say it's hard to find Paxlovid, Pfizer's COVID-19 pillMarketWatch
May-13-22 10:00AM This Is the Most Important Number From Novavax's Q1 EarningsThe Motley Fool
09:06AM 12 stocks to consider for the next leg of the bull marketMarketWatch
May-13-22 08:10AM Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings UpdateZacks Investment Research
06:00AM Is This Vaccine Stock in Trouble -- or Ready for a Rebound?The Motley Fool
May-12-22 10:15AM Here's Why June Could Make Or Break These 3 Vaccine StocksThe Motley Fool
08:02AM Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVIDZacks Investment Research
May-11-22 02:12AM Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss WiderZacks Investment Research
02:08AM Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss EstimatesZacks Investment Research
May-11-22 10:30AM Worried About a Correction? Buy These 2 Evergreen Dividend StocksThe Motley Fool
06:30AM This 1 Thing Could Make Novavax a Vaccine LeaderThe Motley Fool
May-11-22 01:48AM 2 Cash-Rich Dividend Stocks To Counter Growing U.S. Recession RisksInvesting.com
May-10-22 04:48AM Dow books fourth straight day of losses as stocks end mixedMarketWatch
04:42AM Why Biohaven Pharmaceutical Stock Soared TodayThe Motley Fool
May-10-22 03:49AM Dow turns lower heading toward closing bell, while S&P 500, Nasdaq rise in choppy stock-market tradeMarketWatch
02:47AM Novavax (NVAX) Down on Q1 Earnings and Sales Lagging EstimatesZacks Investment Research
May-10-22 02:15AM 2 Extraordinary Events Sent These 2 Stocks Soaring TuesdayThe Motley Fool
01:50AM What is Paxlovid, Pfizer’s COVID antiviral drug, and how effective is it?MarketWatch
May-10-22 01:04AM Despite Positive Signs, Moderna Not A Sure Bet In Post-Pandemic EraInvesting.com
11:53AM Dow erases 500-point rise as stock-market bounce gives wayMarketWatch
May-10-22 09:52AM Dow up more than 300 points as stocks bounce after 3-day selloffMarketWatch
09:27AM Here's a list of 50 companies that are well-armed to beat back inflationMarketWatch
May-10-22 09:23AM The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO LeavesBenzinga
09:00AM Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to KnowZacks Investment Research
May-10-22 08:09AM Here's a list of 50 companies that are well-armed to beat back inflationMarketWatch
07:47AM New York Gov. Hochul tests positive for COVID, as two omicron subvariants spread across Empire StateMarketWatch
May-10-22 07:00AM Novavax's 22% Post-Earnings Plunge: 5 Factors That Took TollBenzinga
06:20AM Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?Zacks Investment Research
May-09-22 02:53AM Why BioNTech Stock Climbed TodayThe Motley Fool
11:09AM J&J (JNJ) Updates COVID Jab Label to Include Blood Clot RiskZacks Investment Research
May-09-22 10:31AM New York Gov. Hochul tests positive for COVID, as two omicron subvariants spread across Empire StateMarketWatch
08:16AM New study finds omicron no less severe than earlier variants, and not just more transmissibleMarketWatch
May-09-22 08:13AM Jim Cramer Shares His Thoughts On Chubb, Novavax And MoreBenzinga
07:05AM Could Novavax Stock Help You Retire a Millionaire?The Motley Fool
May-07-22 08:07AM 2 Healthcare Stocks That Could Make You RicherThe Motley Fool
07:57AM Why GSK May Have Bet Too Big on a Pandemic PipelineThe Motley Fool
May-07-22 07:03AM 3 Unstoppable Stocks to Buy in MayThe Motley Fool
01:52AM Novavax: Don't Catch The Falling KnivesSeeking Alpha
May-06-22 04:15AM Theravance's (TBPH) Q1 Earnings and Sales Miss EstimatesZacks Investment Research
01:07AM Drug companies are making an accounting change after the SEC cracked down on BiogenMarketWatch
May-06-22 12:14PM Fundamentals Of U.S. Stocks Dominating Major Indices Are More Important Than EverInvesting.com
11:30AM Is Pfizer Too Dependent on COVID-19 Revenue?The Motley Fool
May-06-22 10:45AM 3 Top Biotech Stocks to Buy Right NowThe Motley Fool
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brands. This segment also engages in the research and development, as well as contract manufacturing activities. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; Immunicum AB (publ); Immutep Limited; BioNTech AG; Neofluidics, LLC; Kite Pharma, Inc.; Leap Therapeutics, Inc.; Nektar Therapeutics; and Zenith Epigenetics Ltd., as well as development agreement with Antares Pharma, Inc. It also has a collaboration agreement with Aileron Therapeutics, Inc. The company was founded in 1849 and is headquartered in New York, New York.
Cap:    |  Volume (24h):